DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,115 filers reported holding DANAHER CORPORATION in Q3 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,870,000 | +16.9% | 23,871 | +0.2% | 0.64% | -7.4% |
| Q3 2019 | $3,310,000 | +21.3% | 23,824 | +26.1% | 0.69% | +16.7% |
| Q2 2019 | $2,729,000 | +15.3% | 18,893 | +5.4% | 0.59% | +2.8% |
| Q1 2019 | $2,366,000 | +36.2% | 17,920 | +0.7% | 0.58% | +11.2% |
| Q4 2018 | $1,737,000 | -11.3% | 17,789 | -1.3% | 0.52% | +26.2% |
| Q3 2018 | $1,959,000 | +7.0% | 18,032 | +2.0% | 0.41% | -3.3% |
| Q2 2018 | $1,831,000 | -16.4% | 17,681 | -20.0% | 0.43% | -30.4% |
| Q1 2018 | $2,190,000 | +6.8% | 22,103 | +6.3% | 0.61% | +17.7% |
| Q4 2017 | $2,051,000 | +14.6% | 20,795 | +1.2% | 0.52% | +7.2% |
| Q3 2017 | $1,790,000 | +15.6% | 20,539 | +7.3% | 0.48% | -1.0% |
| Q2 2017 | $1,548,000 | +8.6% | 19,149 | +15.6% | 0.49% | -4.9% |
| Q1 2017 | $1,426,000 | +6.6% | 16,564 | +0.1% | 0.52% | -1.3% |
| Q4 2016 | $1,338,000 | – | 16,543 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |